SKIN & AESTHETICS
Auroa Peptides Reads the Skin Remodeling Studies
A science-grounded reading desk for the published literature on GHK-Cu and the GLOW research blend — what each was studied for, in which models, and how strong the evidence actually is.
The short version
Auroa Peptides is a reading desk, not a store. It collects what the peer-reviewed literature actually says about two compounds in the Skin & Aesthetics research space: GHK-Cu and the GLOW multi-peptide blend. A peptide is a short chain of amino acids — the same building blocks that make up proteins, only far smaller. Both entries here have been studied because they seem to nudge parts of the skin's repair and remodeling machinery: rebuilding collagen and elastin scaffolding, growing new blood vessels, or helping migrating repair cells arrive where they are needed.
This site does one job: it tells you, in plain language and with citations, what each peptide (or blend) was tested on, in which models, and how far that evidence actually reaches. Much of it stops well short of humans. None of these is an approved medicine for systemic use. We do not sell anything, we do not give medical advice, and we never list a human dose.
What are research peptides?
Proteins in your body — the collagen meshwork of your skin, an enzyme in your bloodstream, a signaling hormone — are long chains of amino acids folded into a precise shape. A peptide is a much shorter chain of the same amino acids, sometimes only three or four links long. Because they are small and specific, peptides can act like keys that fit particular locks (receptors or enzymes) on the surface of cells, switching certain biological processes on or off.
A research peptide is one that has been synthesized and studied in the laboratory — in cell cultures, in animals, occasionally in small human trials — but has not been approved by a regulatory agency as a medicine. A laboratory-research label describes the material sold under it; it does not describe the separate prescription pathway for compounded GHK-Cu, and human safety and effectiveness remain uncertain. When this site reports a number, it reports it exactly as the study did — for example, stimulation began at 10 picomolar in human fibroblast cultures — never as a recommendation for people.
How these fit into skin and aesthetics research
The two entries on this desk approach skin repair from different angles, which is exactly what makes them worth reading together.
- GHK-Cu is the lead. It is a three-amino-acid peptide chelated to a copper(II) ion, drawn from a sequence within type I collagen itself, and its most consistent research signal is stimulating dermal fibroblasts to make more collagen, elastin, and the proteoglycan decorin [4]. It is a legal cosmetic ingredient in topical form (widely sold as Copper Tripeptide-1), with the most human evidence of the two — mostly in small dermatology trials [1]. Compounded GHK-Cu requires a prescription, with access subject to a provider's review; it is not an FDA-approved medicine.
- GLOW is a multi-peptide research blend, combining GHK-Cu with BPC-157 and TB-500 in a single formulation. The combination thesis is complementary coverage: the matrix-building signal from GHK-Cu, the angiogenic (new-vessel) signal from BPC-157, and the cell-migration signal from TB-500 [8]. No study has tested the three-peptide blend as a unit in humans; all claims rest on single-constituent literature [9].
Use the pages to read each in depth, or compare these peptides side by side.
A note on how this desk reads the literature
Auroa Peptides is a cross-referenced literature digest. Each page summarizes the peer-reviewed studies for that compound or blend, cites them by number, and links to a shared references list. Where the evidence is in vitro, animal-only, or from a small-scale topical trial, we say so plainly — because that context is part of the record, not a footnote to it. We describe research findings and the cited cautions that come with them; we do not recommend, prescribe, or sell. The goal is a measured, accurate map of what is known about these skin research peptides — where the science is solid, where it is still mostly promise, and what an honest reading of the literature actually looks like.
GHK-Cu
A copper-binding tripeptide that signals dermal fibroblasts to rebuild collagen and elastin — the most-studied skin remodeling compound on this desk, with the broadest human topical evidence.
Read the research →
GLOW (research blend)
Three peptides combined — GHK-Cu, BPC-157, and TB-500 — each with a distinct repair role: matrix synthesis, vascular growth, and cell migration. No blend-level clinical trial exists yet.
Read the research →